Profil
Peter Jarrett is Chief Technical Officer at Ocular Therapeutix, Inc. since 2024 and has been with the company since 2007.
Formerly, Dr. Jarrett was Head-Research & Development at Wyeth Holdings LLC, Vice President-Research & Development at Focal, Inc. from 1993 to 2001, and Vice President-Biomaterials Research & Development at Genzyme Corp.
from 2001 to 2007.
Education includes undergraduate studies at Connecticut College and a doctorate from The Institute of Materials Science.
Postes actifs de Peter Jarrett
| Sociétés | Poste | Début |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Directeur Technique/Scientifique/R&D | 01/01/2007 |
Anciens postes connus de Peter Jarrett
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/07/2007 |
Focal, Inc.
Focal, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures synthetic liquid surgical sealant | Directeur Technique/Scientifique/R&D | 01/01/2001 |
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Directeur Technique/Scientifique/R&D | - |
Formation de Peter Jarrett
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Process Industries |
Focal, Inc.
Focal, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures synthetic liquid surgical sealant | Process Industries |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Connecticut College
Connecticut College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Institute of Materials Science
The Institute of Materials Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















